Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata.
V
V
De Leo
A
A
la Marca
G
G
Morgante
F M
FM
Severi
F
F
Petraglia
D000328:Adult; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007889:Leiomyoma / Q000188:drug therapy* / Q000473:pathology; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000502:physiology / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014599:Uterus / Q000473:pathology*
D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I